anmelden
SLI
2.136,99
PKT
+14,15
PKT
+0,67
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.07.20 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.07.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 23.07.20 | Roche overweight | JP Morgan Chase & Co. | |
| 23.07.20 | Roche overweight | Barclays Capital | |
| 23.07.20 | UBS Underweight | Barclays Capital | |
| 23.07.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 23.07.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 23.07.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.07.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 23.07.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 22.07.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.07.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 22.07.20 | Novartis Hold | HSBC | |
| 22.07.20 | Novartis Neutral | Credit Suisse Group | |
| 22.07.20 | Givaudan Hold | Deutsche Bank AG | |
| 22.07.20 | UBS Hold | Deutsche Bank AG | |
| 22.07.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 22.07.20 | Givaudan buy | Kepler Cheuvreux | |
| 22.07.20 | UBS Outperform | Credit Suisse Group | |
| 22.07.20 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 22.07.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 22.07.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 22.07.20 | UBS overweight | JP Morgan Chase & Co. | |
| 22.07.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 21.07.20 | Givaudan verkaufen | Credit Suisse Group | |
| 21.07.20 | Givaudan add | Baader Bank | |
| 21.07.20 | Novartis Equal-Weight | Morgan Stanley | |
| 21.07.20 | UBS Equal-Weight | Morgan Stanley | |
| 21.07.20 | Novartis Hold | Kepler Cheuvreux | |
| 21.07.20 | Givaudan buy | Kepler Cheuvreux | |
| 21.07.20 | Holcim buy | UBS AG | |
| 21.07.20 | Givaudan buy | UBS AG | |
| 21.07.20 | Novartis Neutral | UBS AG | |
| 21.07.20 | UBS Sector Perform | RBC Capital Markets | |
| 21.07.20 | UBS Outperform | Credit Suisse Group | |
| 21.07.20 | Holcim overweight | JP Morgan Chase & Co. | |
| 21.07.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 21.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.20 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 21.07.20 | Novartis buy | Jefferies & Company Inc. |